StockClub

RIGL

RIGLRigel Pharmaceuticals, Inc.$ --
Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc.

RIGL

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
70M USD
YoY +21.2%
Operating Income
23M USD
YoY +39.1%
Net Income
268M USD
YoY +1769.2%
EPS
14.88$
YoY +1737.0%

Revenue

$294.3M
FY2024 Q1$29.5M
$29.5M
Q1
FY2024 Q2$66.4M
$66.4M
Q2
FY2024 Q3$121.7M
$121.7M
Q3
FY2024 Q4$179.3M
$179.3M
Q4
FY2025 Q1$53.3M
$53.3M
Q1
FY2025 Q2$155M
$155M
Q2
FY2025 Q3$224.5M
$224.5M
Q3
FY2025 Q4$294.3M
$294.3M
Q4
Actual
+$115M (+64.1%)

Net Income

$367M
FY2024 Q1$-8.2M
$-8.2M
Q1
FY2024 Q2$-9.3M
$-9.3M
Q2
FY2024 Q3$3.1M
$3.1M
Q3
FY2024 Q4$17.5M
$17.5M
Q4
FY2025 Q1$11.4M
$11.4M
Q1
FY2025 Q2$71.1M
$71.1M
Q2
FY2025 Q3$99M
$99M
Q3
FY2025 Q4$367M
$367M
Q4
Actual
+$349.5M (+1999.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$108.6M
Est:$108.6M
FY2020BEAT
$108.6M
FY2021MISS
Actual:$149.2M
Est:$150.6M
FY2021MISS
$149.2M
FY2022BEAT
Actual:$120.2M
Est:$97.8M
FY2022BEAT
$120.2M
FY2023MISS
Actual:$116.9M
Est:$130.2M
FY2023MISS
$116.9M
FY2024BEAT
Actual:$179.3M
Est:$171.8M
FY2024BEAT
$179.3M
FY2025BEAT
Actual:$294.3M
Est:$293.2M
FY2025BEAT
$294.3M

Analyst Estimates